Skip to main content

Table 3 90-Day clinical outcomes among 55 study patients

From: Levels and values of lipoprotein-associated phospholipase A2, galectin-3, RhoA/ROCK, and endothelial progenitor cells in critical limb ischemia: pharmaco-therapeutic role of cilostazol and clopidogrel combination therapy

Variables

Day 0

Day 90

p-value

Mean ulcerative wound (grading)

2.90 ± 1.60

2.11 ± 1.64

< 0.001

Painful sensation due to CLI

92.7% (51)

19.8% (17)

< 0.001

90-day individual clinical outcome

   

Gastric ulcer with bleeding

 

1.8% (1)

 

Status of CLI (90-day end point)

   

Amputation due to worsening CLI

 

10.9% (6)

 

Stationary*

 

34.6% (19)

 

Greater improvement†

 

23.6% (13)

 

Complete healing

 

16.4% (9)

 

Withdraw

 

5.5% (3)

 

Sepsis-cause death

 

5.5% (3)

 

Cardiovascular-caused death

 

1.8% (1)

 

Cancer-cause death

 

1.8% (1)

 
  1. Data expressed as mean ± SD or% (n).
  2. *Defined as the ulcerative wound had more clean without progressive worsening.
  3. †Defined as the ulcerative wound healing with > 50% of the area.